Growing epilepsy amongst population is expected to drive the growth of India levetiracetam market during the forecast period.
According to TechSci Research report, “India Levetiracetam Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Treatment (Myoclonic treatment, Tonic-clonic seizures treatment and Others), By Route of Administration (Oral v/s Intravenous), By Company, By Region, Forecast & Opportunities, FY2027”, the India levetiracetam market is expected to grow at a significant rate during the forecast period for the treatment of epilepsy. Levetiracetam is also effective in treating focal impaired awareness or complex partial seizures, which is making headway for the demand of levetiracetam in the country, thereby driving the market growth. In addition to this, increasing access to epilepsy pharmacotherapy by the populations of India is resulting in increased uptake of newer drugs which is expected to fuel the market growth through FY2027. However, side-effects associated with drug consumption such as weakness, unsteady walking, loss of balance or coordination, confusion, headache, loss of appetite, vomiting, diarrhea, constipation, excessive sleepiness can restrict the market growth over the next few years.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “India Levetiracetam Market”
https://www.techsciresearch.com/report/india-levetiracetam-market/7313.html
The India levetiracetam market is segmented based on source, form, distribution channel, treatment, route of administration, company, and region. Based on route of administration, the market can be fragmented into oral v/s intravenous. The oral route of administration segment dominated the market until FY2020 and is further expected to lead the market in terms of market share during the forecast years on account of its versatility to accommodate various types of drugs. Moreover, the oral route is the most convenient and usually the safest, thereby positively influencing the segmental growth in the upcoming years. Based on source, the market can be categorized into in-house v/s contract manufacturing organizations. The in-house segment dominated the market until FY2020 as most of the leading companies focus on in house production. Contract manufacturing organizations segment is expected to witness significant growth in the market as it saves cost and maximize profits. Besides, high growth in number of contract manufacturers is further contributing to its fast growing CAGR. In terms of form, the market is split into tablet, syrup, and injection. Among them, the tablet segment is anticipated to register high growth in the market over the next 5 years which is attributable to the fact that they are easy to use and are readily available.
IPCA Laboratories Ltd., UCB India Pvt. Ltd., Cipla Limited, Ranbaxy Laboratories Ltd., Torrent Pharmaceuticals Ltd., Unichem Laboratories Ltd., Anuh Pharma Ltd., SVK Laboratories Private Limited, Jubilant Life Sciences Limited, Carise Phamaceuticals Pvt. Ltd. and others are some of the leading players operating in India levetiracetam market. Companies operating in the market are using organic and Go-to-Market strategies such as product launches, mergers and acquisitions, product portfolio expansion and research collaborations to boost their share and increase their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7313
Customers can also request for 10% free customization on this report.
“India levetiracetam market is expected to witness growth during the forecast period as it is used as a single-drug treatment for newly diagnosed focal epilepsy in adults. These focal seizures can be reduced by 50% or more by taking levetiracetam. Additionally, major market players are focusing on strategic collaborations to commercialize their newly developed drugs. This is further expected to create lucrative opportunities for the market growth of India levetiracetam market over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“India Levetiracetam Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Treatment (Myoclonic treatment, Tonic-clonic seizures treatment and Others), By Route of Administration (Oral v/s Intravenous), By Company, By Region, Forecast & Opportunities, FY2027”, has evaluated the future growth potential of India levetiracetam market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India levetiracetam market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/
